Predictors of protease inhibitor-associated adverse events.

Abstract

Risk factors in the development of adverse reactions in HIV-1-infected patients treated with highly active antiretroviral therapy (HAART) containing protease inhibitors are poorly understood. To identify predictors of protease inhibitor-associated adverse events, we are conducting a prospective, cohort, multicenter study on HIV-positive patients starting… (More)

Topics

Cite this paper

@article{Bonfanti2001PredictorsOP, title={Predictors of protease inhibitor-associated adverse events.}, author={Paolo Bonfanti and E Ricci and Simona Landonio and Lucia Valsecchi and Lia Timillero and Ivano Faggion and Thiago Santos Quirino}, journal={Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie}, year={2001}, volume={55 6}, pages={321-3} }